SinoXivBackground Transurethral resection of bladder tumor (TURBT) is the standard treatment for non-muscle-invasive bladder cancer (NMIBC), but the high rates of residual tumor and recurrence remain major c...
Background Robot-assisted radical cystectomy (RARC) has already been a standard treatment for muscle-invasive bladder cancer, with multiport laparoscopic approaches being well-established. However, si...
Background Bladder cancer (BC) is a common urologic malignancy with high recurrence and progression rates, and outcomes for advanced disease remain poor. Peroxisome proliferator-activated receptor gam...
Purpose To evaluate the prognostic value of preoperative hemoglobin-lymphocyte-neutrophil ratio (HLNR) and hemoglobin-lymphocyte-platelet ratio (HLPR) for predicting tumor recurrence at control cystos...
